Valvular Heart Disease and Cardiomyopathy | MyMerci
제안하기
0 / 2000

Valvular Heart Disease and Cardiomyopathy

Unit 6 · Topic 31Valvular Heart Disease and Cardiomyopathy
1.Overview & Pathophysiology

Valvular heart disease is damage to one or more heart valves. A stenotic valve does not open fully, so the chamber behind it must pump harder against resistance (pressure overload). A regurgitant (insufficient) valve does not close fully, so blood leaks backward (volume overload). The mitral and aortic valves are affected most often.

Causes: rheumatic heart disease (especially mitral stenosis, common in low- and middle-income countries), age-related calcification (aortic stenosis in older adults), congenital bicuspid aortic valve, infective endocarditis, myocardial infarction (papillary muscle dysfunction causing mitral regurgitation), and connective tissue disorders.

LesionHemodynamic effectKey consequences
Mitral stenosis (MS)Blocked flow from left atrium to left ventricle during diastoleLeft atrial enlargement → atrial fibrillation, atrial thrombus and embolic stroke; pulmonary congestion → dyspnea, orthopnea, paroxysmal nocturnal dyspnea, hemoptysis; right-sided HF later
Mitral regurgitation (MR)Backflow into left atrium during systoleLeft atrial and ventricular dilation, pulmonary congestion, fatigue, AF
Mitral valve prolapse (MVP)Leaflets bulge into the atrium during systoleUsually benign; palpitations, atypical chest pain, anxiety; may progress to MR
Aortic stenosis (AS)Obstructed left ventricular outflow; left ventricular hypertrophyClassic triad: angina, syncope, dyspnea/HF — once symptoms appear, survival drops sharply without valve replacement; sudden death risk
Aortic regurgitation (AR)Backflow from aorta into left ventricle in diastoleLeft ventricular dilation; wide pulse pressure, bounding pulses; palpitations, HF

Cardiomyopathy is disease of the heart muscle itself.

TypeWhat happensMain problem
Dilated (DCM)Ventricles enlarge, walls thinSystolic dysfunction — weak contraction, low EF (HFrEF)
Hypertrophic (HCM)Thick, stiff left ventricle (often the septum); usually geneticDiastolic dysfunction; left ventricular outflow tract (LVOT) obstruction in many; sudden cardiac death in young people and athletes
RestrictiveStiff ventricles fill poorly (e.g., amyloidosis, sarcoidosis)Diastolic dysfunction, right-sided HF signs
Stress (takotsubo)Transient ventricular dysfunction after severe emotional or physical stressMimics MI; usually recovers

DCM causes include ischemia, alcohol, cocaine, some chemotherapy (anthracyclines), myocarditis, pregnancy (peripartum cardiomyopathy), and genetic variants.

2.Assessment Findings

Murmur recognition

LesionTimingBest heardOther clues
Mitral stenosisDiastolic low-pitched rumbleApex (left lateral position, bell)Opening snap, loud S₁, irregular pulse (AF)
Mitral regurgitationHolosystolic (pansystolic)Apex, radiating to the left axillaS₃
Mitral valve prolapseMidsystolic click, ± late systolic murmurApexClick moves earlier on standing
Aortic stenosisSystolic crescendo–decrescendo (harsh)Right 2nd intercostal space, radiating to the carotidsNarrow pulse pressure, weak delayed pulse
Aortic regurgitationDiastolic blowing decrescendoLeft sternal border (3rd–4th intercostal space), client leaning forwardWide pulse pressure, bounding "water-hammer" pulse, head bobbing; sometimes a bisferiens pulse (two peaks in systole)
HCM (obstructive)Systolic murmurLeft sternal borderLouder with Valsalva or standing (less filling); softer with squatting

General findings: fatigue, exertional dyspnea, orthopnea, palpitations, edema, JVD, crackles, chest pain, dizziness or syncope, reduced activity tolerance.

3.Diagnostics
TestPurpose
Transthoracic echocardiogramMain test: valve area, gradients, regurgitation severity, chamber size, wall thickness, EF
Transesophageal echocardiogramBetter views of mitral valve, prosthetic valves, atrial thrombus, vegetations
ECGAF, left ventricular hypertrophy, left atrial enlargement
Chest X-rayCardiomegaly, pulmonary congestion
BNP / NT-proBNPHeart failure severity
Cardiac MRICardiomyopathy type, fibrosis
Cardiac catheterizationPressures, coronary anatomy before surgery
Genetic testing, family screeningHCM and some DCM
4.Medical Management

Valve disease

  • Heart failure symptoms: diuretics, sodium restriction; GDMT when EF is reduced (see Heart Failure topic)
  • Mitral stenosis: beta blockers or nondihydropyridine calcium channel blockers slow the heart rate and lengthen diastole, improving left ventricular filling — they are helpful, not contraindicated. Anticoagulation with warfarin if AF, prior embolism, or left atrial thrombus (DOACs are not used in moderate–severe rheumatic MS). Percutaneous balloon mitral commissurotomy for suitable valves; surgery otherwise
  • Aortic stenosis: no drug relieves the obstruction. Valve replacement — surgical (SAVR) or transcatheter (TAVR) — once severe AS causes symptoms (or earlier in selected asymptomatic clients, e.g., LVEF below 50%). Use vasodilators (nitrates) and diuretics cautiously; these clients depend on adequate preload
  • Regurgitant lesions: afterload reduction and BP control; surgical repair or replacement (transcatheter edge-to-edge repair for selected MR)
  • MVP: reassurance; beta blocker for troublesome palpitations

Prosthetic valves

ValveDurabilityAnticoagulation
MechanicalLifelongLifelong warfarin — INR target commonly 2.5 (aortic) or 3.0 (mitral or higher risk). DOACs are contraindicated
Biological (tissue)About 10–15 years; may need reinterventionShort-term anticoagulant or antiplatelet therapy; no lifelong warfarin in most clients

Endocarditis prophylaxis (current AHA guidance): antibiotics before dental procedures that manipulate gums or perforate oral mucosa only for high-risk clients — prosthetic valve or prosthetic material used for repair, previous infective endocarditis, certain congenital heart disease, and cardiac transplant with valvulopathy. Native valve disease alone (including AS and MVP) does not require prophylaxis. Good oral hygiene and regular dental care matter for everyone. Typical regimen: amoxicillin 2 g orally 30–60 minutes before the procedure; with penicillin allergy, azithromycin or clarithromycin 500 mg, or doxycycline 100 mg (clindamycin is no longer recommended).

Cardiomyopathy

  • DCM: HFrEF therapy (ARNI/ACE inhibitor/ARB, beta blocker, MRA, SGLT2 inhibitor), diuretics; goal is to improve pumping (contractility) and prevent remodeling. ICD or CRT when criteria are met; transplant or ventricular assist device for advanced disease. Abstain from alcohol
  • HCM: beta blockers or verapamil/diltiazem to slow the heart rate and improve filling (use verapamil/diltiazem cautiously with severe outflow obstruction and low BP). Mavacamten (cardiac myosin inhibitor) for symptomatic obstructive HCM — available through a restricted (REMS) program with regular echocardiograms because it can lower EF and cause HF; contraindicated with certain CYP2C19/CYP3A4 inhibitors and inducers; may cause fetal harm, so effective contraception is required (it can reduce the effect of combined hormonal contraceptives). Septal myectomy or alcohol septal ablation for refractory obstruction; ICD for high sudden-death risk
  • HCM — avoid drugs that worsen outflow obstruction: positive inotropes such as digoxin, pure vasodilators (nitrates, dihydropyridine calcium channel blockers), and aggressive diuresis or dehydration. Hypotension in obstructive HCM is treated with fluids and phenylephrine, not inotropes
  • Restrictive: treat the cause (e.g., tafamidis for transthyretin amyloidosis); careful diuresis

Drug safety reminders: beta blockers (bradycardia, hypotension, do not stop abruptly), verapamil (hypotension, constipation, avoid in HFrEF), warfarin (INR, bleeding, pregnancy contraindication), diuretics (hypokalemia, volume depletion).

5.Nursing Interventions

Listed in priority order.

  1. Airway, breathing, circulation — for pulmonary congestion: high-Fowler's position, oxygen to target SpO₂, prepare IV diuretic
  2. Syncope in aortic stenosis — treat as serious: it signals critically limited cardiac output and risk of dysrhythmia and sudden death. Place on continuous ECG monitoring, ensure safety, report immediately
  3. Monitor rhythm — new AF in MS or MR raises embolic risk; watch for neurologic changes
  4. Fluid balance — daily weight, intake and output; avoid dehydration in AS and HCM
  5. Anticoagulation safety — INR, bleeding precautions, fall prevention
  6. Activity — pace activities, rest periods; stop and report chest pain, dyspnea, or dizziness
  7. After valve surgery or TAVR — monitor for bleeding, tamponade, conduction block (a pacemaker may be needed after TAVR), stroke, and access-site complications
6.Client Education
  • Report increasing dyspnea, fatigue, fainting, chest pain, palpitations, or rapid weight gain
  • HCM: avoid dehydration, hot tubs/saunas, and heavy alcohol; avoid intense, strenuous exertion unless cleared by an HCM specialist — mild-to-moderate recreational activity is generally encouraged under current guidance. First-degree relatives need screening
  • MVP: most people need no restrictions; limit caffeine and other stimulants if palpitations bother you; follow-up echocardiograms as advised
  • Mechanical valve: lifelong warfarin, INR tests, consistent vitamin K intake, medical alert identification; plan pregnancy with the cardiologist
  • Tell every dentist and provider about your valve; practice good dental hygiene; ask whether you need antibiotics before dental work (only high-risk conditions)
  • Report fever, chills, or new fatigue (possible endocarditis)
  • DCM: follow HF self-care (daily weight, sodium limit, medications); avoid alcohol and cocaine
7.Complications & Red Flags
ComplicationWhat to watch for
Heart failure / pulmonary edemaOrthopnea, PND, crackles, hypoxemia
Atrial fibrillation and embolic strokeIrregular pulse, sudden neurologic deficit
Sudden cardiac deathHCM, severe AS — syncope is a warning sign
Infective endocarditisFever, new or changed murmur, embolic signs
Prosthetic valve thrombosisNew dyspnea, muffled valve clicks, embolism
BleedingWarfarin with high INR
8.High-Yield Points
  • Stenosis = valve won't open; regurgitation = valve won't close
  • MS → diastolic rumble at apex, AF, embolism, PND; most often rheumatic
  • MR → holosystolic murmur at apex radiating to axilla
  • AS → systolic murmur at right 2nd ICS to carotids; angina, syncope, HF; syncope = high sudden-death risk
  • AR → diastolic murmur, wide pulse pressure, bounding pulse
  • Beta blockers help in MS (longer filling time)
  • HCM → avoid digoxin, nitrates, dehydration; beta blocker or verapamil; sudden death in athletes
  • DCM → systolic failure; goal is better contractility and HF therapy
  • Mechanical valve → lifelong warfarin; DOACs contraindicated
  • Endocarditis prophylaxis only for high-risk clients (prosthetic valve, prior IE)

Country Notes

United States

  • Degenerative (calcific) aortic stenosis in older adults is the most common valve lesion requiring intervention; TAVR is widely available.
  • Rheumatic heart disease is uncommon and seen mainly in immigrants from endemic regions.

Philippines

  • Rheumatic heart disease remains a major cause of valve disease in young adults, especially mitral stenosis; ask about childhood sore throats, joint pains, and benzathine penicillin injections every 3–4 weeks.
  • Clients with RHD and AF generally need warfarin with INR monitoring; access to regular INR testing in rural areas should be part of discharge planning.

다음 이론을 계속 학습하려면 로그인하세요.

로그인하고 계속 학습
컨텐츠를 그만볼래?

필기노트, 하이라이터, 메모는 잘 쓰고 있어?

내보내줘
어떤 폴더에 저장할래?

컨텐츠 노트에는 총 0개의 폴더가 있어!

폴더 만들기
컨텐츠 만들기
만들기
신고했어요.

운영진이 검토할게요!

해당 유저를 차단했어요.

마이페이지에서 차단한 회원을 관리할 수 있어요.